On World AIDS Day, ‘Lancet HIV’ publishes reports born out of Sunnylands retreat

Tuesday, December 1, 2020

On World AIDS Day, The Annenberg Foundation Trust at Sunnylands is proud to join citizens throughout the world who are fighting against HIV/AIDS, supporting people living with HIV, and honoring those who have died from an AIDS-related illness.

It is in this spirit that Sunnylands is pleased to share two seminal manuscripts, published today in the noted scientific journal Lancet HIV, which were born out of Sunnylands’ exclusive retreat program.

Each of these scientific manuscripts outlines a key facet relating to a potential HIV cure in the coming years: the Target Product Profile (TPP) describes what a future cure must “look like” to be adequately effective, manufactured, and distributed; and the HIV Cure Africa Acceleration Partnership (HCAAP) is a proposed international public-private partnership organization that would focus on accelerating the discovery, design, and acceptance of HIV cure products.

Both findings derive in large part from discussions, and subsequent follow-on efforts, at a key 2019 retreat hosted at the historic Sunnylands estate in Rancho Mirage, California.

2019 HIV retreat

Participants of the 2019 retreat, “Sunnylands Summit: The Path Toward Ending HIV,” convene in the Sunnylands atrium.

On February 7-9, 2019, Sunnylands partnered with the International AIDS Society, the world’s largest association of HIV professionals with members from more than 180 countries, to host the retreat titled, “Sunnylands Summit: The Path Toward Ending HIV.” Over three days, thirty high-level HIV/AIDS researchers, advocates, policymakers, and private-sector representatives met for frank discussions on prospects and requirements for developing a cure for HIV, and how to ensure its widest possible distribution and access.

This retreat built on an earlier, landmark HIV retreat that was hosted at Sunnylands in 2013, at which participants agreed that research toward a cure was a viable goal and unlocked millions of dollars of new investment in cure research

Sunnylands was honored to play an important part in this vital dialogue and looks forward to continuing to support such discussions in the future.